Opportunity

SAM #36C26126D0032

Award for Oncology and Molecular Laboratory Testing Services at VA Central California Healthcare System

Buyer

VA Network Contracting Office 21

Posted

April 24, 2026

Identifier

36C26126D0032

NAICS

541380, 621511

This award summary covers the Department of Veterans Affairs' procurement of specialized oncology and molecular laboratory testing services for the VA Central California Healthcare System in Fresno, CA.

  • Government Buyer:

    • Department of Veterans Affairs (VA)
    • Network Contracting Office 21 (NCO21), Veterans Integrated Services Network 21
    • VA Central California Healthcare System, Fresno, CA
  • OEMs and Vendors:

    • NeoGenomics Laboratories, Inc. (OEM and service provider)
  • Products/Services Requested:

    • Oncology and molecular laboratory testing services
    • Includes proprietary NeoTYPE cancer profiles and related assays
    • Comprehensive cancer profiling tests combining:
      • Next-Generation Sequencing (NGS)
      • Fluorescence In Situ Hybridization (FISH)
      • Immunochemistry
      • Molecular diagnostics
      • Cytogenetics
      • Liquid biopsy molecular testing
    • Specimen packaging, pickup, and transport
    • No specific part numbers or quantities are listed
  • Unique or Notable Requirements:

    • Sole source, IDIQ contract with five one-year ordering periods
    • Estimated total value: $3.5 million; ceiling: $5 million
    • Services must include proprietary NeoTYPE cancer profiles
    • Option to extend services for up to six months beyond the final ordering period
  • Place of Performance:

    • VA Central California Healthcare System, 2815 E Clinton Ave, Fresno, CA 93703
  • Award Details:

    • Awarded under solicitation 36C26126Q0374, award number 36C26126D0032
    • Service code Q301, NAICS code 541380
    • Contractor address: 9490 NeoGenomics Way, Fort Myers, FL 33912

Description

Award Notice

View original listing